Showing 201-210 of 1698 results for "".
The Multiple Sclerosis Prodrome: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-prodrome-past-present-and-future/31973/Multiple sclerosis may cause symptoms and disability prior to classically defined disease onset.Diagnosis and Treatment of Depression and Anxiety in People Who Have Experienced a Stroke and Their Caregivers
https://practicalneurology.com/diseases-diagnoses/stroke/diagnosis-and-treatment-of-depression-and-anxiety-in-people-who-have-experienced-a-stroke-and-their-caregivers/32190/Understanding and addressing the correlation between the mental health of people who have experienced a stroke and their caregivers may help improve secondary prevention and quality of life for these individuals.Cerebral Vasoconstriction and Vasospastic Angina Secondary to Pheochromocytoma
https://practicalneurology.com/diseases-diagnoses/headache-pain/cerebral-vasoconstriction-and-vasospastic-angina-secondary-to-pheochromocytoma/31979/This is the first reported case of pheochromocytoma associated with both RCVS and vasospastic angina in the same patient.Posttraumatic Headache Associated with Mild Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/posttraumatic-headache-associated-with-mild-traumatic-brain-injury/31993/Diagnosis and treatment of posttraumatic headache associated with mTBI, including onset, headache characteristics, and persistenceCaregiver Screening Tools for Agitation in Alzheimer’s Disease
https://practicalneurology.com/programs/cme/caregiver-screening-tools-for-agitation-in-alzheimers-disease/28795/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Medical Marijuana and Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/medical-marijuana-and-movement-disorders/31951/Medical marijuana can be a useful tool for addressing nonmotor symptoms of movement disorders.The Central Vein Sign
https://practicalneurology.com/diseases-diagnoses/imaging-testing/the-central-vein-sign/31627/Is 1.5 T MRI still relevant for diagnosis of multiple sclerosis?Dementia Insights: What Do Animal Models of Alzheimer’s Disease Tell Us?
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-what-do-animal-models-ofalzheimers-disease-tell-us/31560/Understanding pathologic mechanisms provides test beds for finding treatments.Safety, Efficacy, and Black Box Warnings: Challenges Associated With Off-Label Treatments of AAD
https://practicalneurology.com/programs/cme/safety-efficacy-and-black-box-warnings-challenges-associated-with-off-label-treatments-of-aad/27099/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Evaluating Heterogeneous Treatment Effects in Pursuit of Personalized Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/evaluating-heterogeneous-treatment-effects-in-pursuit-of-personalized-multiple-sclerosis-care/33141/Heterogeneous treatment effect methodologies can be used to enhance individualized care for people with multiple sclerosis.